-
Publication Date2022-10
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia
Ottaviano, Giorgio; Georgiadis, Christos; Gkazi, Soragia Athina, et al
Science Translational Medicine, v.14, no.668
-
Publication Date2021-01
Profiling genome-wide specificity of CRISPR-Cas9 using digenome-seq
Daesik Kim; Jin-Soo Kim
Methods in molecular biology (Clifton, N.J.), v.2162, pp.233 - 242
-
Publication Date2020-05
Protein Kinase A Catalytic Subunit Is a Molecular Switch that Promotes the Pro-tumoral Function of Macrophages
Yi Rang Na; Jung Won Kwon; Da Young Kim, et al
CELL REPORTS, v.31, no.6, pp.107643
-
Publication Date2020-01
Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice
Ji-Su Lee; Jae Y. Lee; Dong W. Song, et al
NUCLEIC ACIDS RESEARCH, v.48, no.1, pp.130 - 140